Highest-Paid CEOs
CEO pay continues to outpace the pay of working people. In the past 10 years, CEO pay at S&P 500 companies increased more than $340,000 a year to an average of $14.8 million in 2019. Meanwhile, the average production and nonsupervisory worker saw a wage increase of $836 a year, earning on average just $41,442 in 2019.
Search by Company Name or Ticker
| Ticker | Company | CEO | Year | CEO Pay Sort ascending |
|---|---|---|---|---|
| AHT | Ashford Hospitality Trust Inc. | Robison Hays | 2023 | $2,413,054 |
| PRMW | Primo Water Corp. | Thomas Harrington | 2023 | $2,405,756 |
| SRG | Seritage Growth Properties | Andrea Olshan | 2023 | $2,404,615 |
| DBVT | DBV Technologies | Daniel Tassé | 2023 | $2,404,486 |
| IBOC | International Bancshares Corp. | Dennis Nixon | 2023 | $2,403,025 |
| MTRX | Matrix Service Co. | John Hewitt | 2023 | $2,401,993 |
| AMPY | Amplify Energy Corp. | Martyn Willsher | 2023 | $2,401,494 |
| HLBZ | Micromobility.com Inc. | Salvatore Palella | 2023 | $2,397,996 |
| NODK | NI Holdings, Inc. | Michael Alexander | 2023 | $2,397,889 |
| BFST | Business First Bancshares, Inc. | David Melville Jude | 2023 | $2,397,380 |
| CTV | Innovid Corp. | Zvika Netter | 2023 | $2,396,888 |
| CBTX | Stellar Bancorp, Inc. | Robert Franklin | 2023 | $2,395,804 |
| WULF | Terawulf Inc. | Paul Prager | 2023 | $2,394,178 |
| EDIT | Editas Medicine, Inc. | Gilmore O’Neill | 2023 | $2,392,309 |
| SGMO | Sangamo Therapeutics, Inc. | Alexander Macrae | 2023 | $2,392,272 |
| HBIO | Harvard Bioscience Inc. | James Green | 2023 | $2,392,240 |
| RES | RPC Inc. | Ben Palmer | 2023 | $2,391,450 |
| GLYC | Glycomimetics Inc. | Harout Semerjian | 2023 | $2,389,418 |
| SPRO | Spero Therapeutics, Inc. | Ankit Mahadevia | 2023 | $2,385,905 |
| XOS | Xos, Inc. | Dakota Semler | 2023 | $2,380,865 |